Literature DB >> 10691303

Immunolocalization of tenascin-C in human type II fiber atrophy.

B G Schoser1, A Faissner, H H Goebel.   

Abstract

Tenascin-C is a multifunctional extracellular matrix glycoprotein with stimulatory and anti-adhesive or inhibitory properties for axon growth. Its location and discontinuous expression are restricted in innervated muscle tissues. Tenascin-C accumulated interstitially among human denervated muscle fibers and close to normal-sized fibers. To expand our knowledge of the expression of tenascin-C in human neuromuscular disorders, we investigated immunohistologically 20 human muscle specimens with type II myofiber atrophy of children and adults. Tenascin-C immunoreactivity in adult type II atrophy was frequent, and accumulation in children was sparse and weak. In both groups, tenascin-C immunoreactivity was found: 1. Interstitially around normal-sized type II muscle fibers. 2. Around atrophic type II muscle fibers. 3. Around small-caliber myofibers with centrally located nuclei. These results indicate that tenascin-C immunoreactivity: (1) is detectable around early denervated and reinnervated muscle fibers and, therefore, (2) may reflect in part the molecularly ongoing process of denervation and reinnervation in human type II fiber atrophy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10691303     DOI: 10.1385/JMN:13:1-2:167

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  30 in total

1.  Tenascin-C expression correlates with macrophage invasion in Duchenne muscular dystrophy and in myositis.

Authors:  D Gullberg; T Velling; G Sjöberg; K Salmivirta; B Gaggero; C F Tiger; L Edström; T Sejersen
Journal:  Neuromuscul Disord       Date:  1997-01       Impact factor: 4.296

2.  The complete cDNA sequence of human hexabrachion (Tenascin). A multidomain protein containing unique epidermal growth factor repeats.

Authors:  D E Nies; T J Hemesath; J H Kim; J R Gulcher; K Stefansson
Journal:  J Biol Chem       Date:  1991-02-15       Impact factor: 5.157

Review 3.  The tenascin gene family in axon growth and guidance.

Authors:  A Faissner
Journal:  Cell Tissue Res       Date:  1997-11       Impact factor: 5.249

4.  Pathogenesis of myasthenia gravis. Acetylcholine receptor-related antigenic determinants in tumor-free thymuses and thymic epithelial tumors.

Authors:  T Kirchner; S Tzartos; F Hoppe; B Schalke; H Wekerle; H K Müller-Hermelink
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

5.  The fine structure of type II muscle fiber atrophy.

Authors:  J R Mendell; W K Engel
Journal:  Neurology       Date:  1971-04       Impact factor: 9.910

6.  Tenascin-X deficiency is associated with Ehlers-Danlos syndrome.

Authors:  G H Burch; Y Gong; W Liu; R W Dettman; C J Curry; L Smith; W L Miller; J Bristow
Journal:  Nat Genet       Date:  1997-09       Impact factor: 38.330

Review 7.  Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions.

Authors:  H P Erickson
Journal:  Curr Opin Cell Biol       Date:  1993-10       Impact factor: 8.382

8.  Concerted action of tenascin-C domains in cell adhesion, anti-adhesion and promotion of neurite outgrowth.

Authors:  D Fischer; M Brown-Lüdi; T Schulthess; R Chiquet-Ehrismann
Journal:  J Cell Sci       Date:  1997-07       Impact factor: 5.285

9.  Expression of cytotactin in the normal and regenerating neuromuscular system.

Authors:  J K Daniloff; K L Crossin; M Pinçon-Raymond; M Murawsky; F Rieger; G M Edelman
Journal:  J Cell Biol       Date:  1989-02       Impact factor: 10.539

10.  Expression of several adhesive macromolecules (N-CAM, L1, J1, NILE, uvomorulin, laminin, fibronectin, and a heparan sulfate proteoglycan) in embryonic, adult, and denervated adult skeletal muscle.

Authors:  J R Sanes; M Schachner; J Covault
Journal:  J Cell Biol       Date:  1986-02       Impact factor: 10.539

View more
  1 in total

1.  Mechano-regulated tenascin-C orchestrates muscle repair.

Authors:  Martin Flück; Sonja I Mund; Johannes C Schittny; Stephan Klossner; Anne-Cécile Durieux; Marie-Noëlle Giraud
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-29       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.